Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis.
Sunny GoelRavi Teja PasamSrilekha ChavaAbhishek SharmaBilal Ahmad MalikSergey AyzenbergRobert FrankelJacob ShaniUmesh GidwaniPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Between 3 and 4 years of follow-up, patients receiving absorb BVS did not have significantly different outcomes, in terms of TLF, TV-MI, TLR, DT, and cardiac mortality, compared to DES.